tirzepatide weight loss clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide weight loss maintenance study

Excellent aftercare

New Drug Forms Some online compounding pharmacies have begun selling oral forms of semaglutide and tirzepatide, which are typically administered with an injection

Beyond weight loss, Eli Lilly's research showed that tirzepatide improved blood sugar control, reduced cardiovascular risk markers, and demonstrated tolerability across diverse patient populations

Couldnt recommend them enough! The Staff at Rivas, located in Waldorf, MD, are genuinely concerned and display expertise that has made a lasting impact on my progress

Step 4: Learn proper injection technique If you are new to subcutaneous injections, proper technique matters

Meanwhile, the GIP pathway enhances metabolic efficiency, improves how your body processes fat, and supports healthier insulin responses